Jimmy(Liqiang) was selected as a finalist for the Texas Health Catalyst Program and presented a translational nano-platform that harnesses self-specific T-cell immnue reponses to advance cancer treatment.
Jimmy(Liqiang) was selected as a finalist for the Texas Health Catalyst Program and presented a translational nano-platform that harnesses self-specific T-cell immnue reponses to advance cancer treatment.